<bill session="116" type="h" number="3109" updated="2022-11-01T06:32:24Z">
  <state datetime="2019-06-05">REFERRED</state>
  <status>
    <introduced datetime="2019-06-05"/>
  </status>
  <introduced datetime="2019-06-05"/>
  <titles>
    <title type="display">GEDI Act</title>
    <title type="official" as="introduced">To provide grants to better understand and reduce gestational diabetes, and for other purposes.</title>
    <title type="short" as="introduced">GEDI Act</title>
    <title type="short" as="introduced">Gestational Diabetes Act of 2019</title>
  </titles>
  <sponsor bioguide_id="E000179"/>
  <cosponsors>
    <cosponsor bioguide_id="B001248" joined="2019-06-05"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-06-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-06-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="4819" relation="unknown"/>
    <bill session="116" type="h" number="6637" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Sex and reproductive health"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2020-08-11T20:10:19Z" status="Introduced in House">Gestational Diabetes Act of 2019 or the GEDI Act

This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes (i.e., diabetes occuring during pregnancy) research project to expand and enhance surveillance data and public health research about gestational diabetes.&#160;

The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and tribal diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and&#160;related complications.</summary>
</bill>
